Table 6 Primary-site-specific mean health-related quality of life (HRQoL) score among hospitalized cancer patients
Primary site of Cancer | Sample size N (%) | Mean HRQoL score | VAS Score | ||
|---|---|---|---|---|---|
Mean (95%CIs) | p-value | Mean (95%CIs) | p-value | ||
Bladder cancer | 19 (0.8%) | 0.579(0.371,0.788) | < 0.001 | 56.84(49.51,64.17) | < 0.001 |
Bone cancer | 73 (3.2%) | 0.392(0.271,0.513) | 54(50.6,57.4) | ||
Brain and other nervous system cancers | 24 (1%) | 0.326(0.127,0.525) | 47.5(39.29,55.71) | ||
Breast cancer | 309 (13.1%) | 0.648(0.614,0.682) | 56.8(55.07,58.52) | ||
Cancer of unknown primary site | 17 (0.7%) | 0.624(0.499,0.749) | 57.06(50.82,63.29) | ||
Cervical and Uterine cancers | 130 (5.5%) | 0.55(0.486,0.615) | 58.12(55.66,60.57) | ||
Colorectal cancer | 264 (11.2%) | 0.595(0.554,0.636) | 56.41(54.75,58.07) | ||
Head and Neck cancer (excluding Oral cavity) | 112 (4.7%) | 0.533(0.461,0.605) | 57.81(55.01,60.62) | ||
Oral cancer | 201 (8.5%) | 0.507(0.462,0.552) | 58.76(56.72,60.79) | ||
Kidney and ureter cancer | 18 (0.8%) | 0.637(0.493,0.782) | 57.22(49.44,65) | ||
Leukemia | 196 (8.3%) | 0.562(0.508,0.616) | 53.65(51.63,55.66) | ||
Lung cancer | 144 (6.1%) | 0.488(0.416,0.56) | 54.55(52.09,57.01) | ||
Lymphoma | 166 (7%) | 0.562(0.494,0.63) | 58.1(55.62,60.59) | ||
Multiple Myeloma | 71 (3%) | 0.255(0.145,0.365) | 49.3(44.77,53.82) | ||
Ovarian cancer | 163 (6.9%) | 0.586(0.531,0.641) | 54.17(51.65,56.69) | ||
Pancreatic and Biliary cancers | 92 (3.9%) | 0.499(0.425,0.572) | 51.58(48.58,54.58) | ||
Prostate cancer | 21 (0.9%) | 0.54(0.35,0.729) | 54.29(48.98,59.59) | ||
Penile cancer | 9 (0.4%) | 0.327(-0.091,0.745) | 57.78(45.91,69.64) | ||
Skin cancer | 10 (0.4%) | 0.289(-0.06,0.639) | 56(47.11,64.89) | ||
Soft tissue tumors | 28 (1.2%) | 0.532(0.364,0.7) | 54.29(48.94,59.63) | ||
Testicular cancer | 59 (2.5%) | 0.771(0.702,0.84) | 57.97(53.19,62.75) | ||
Upper GI tract cancers | 203 (8.6%) | 0.579(0.527,0.631) | 53.23(51.25,55.21) | ||
Other hematological cancers (exc. Lymphomas and Leukemia) | 12 (0.5%) | 0.229(-0.083,0.541) | 40.83(31.66,50) | ||
Other cancers | 16 (0.7%) | 0.601(0.414,0.787) | 53.13(46.83,59.42) | ||